HIGH SPECIFICITY AND HIGH SENSITIVITY DETECTION BASED ON STERIC HINDRANCE & ENZYME-RELATED SIGNAL AMPLIFICATION

• US 20130115594A1
• Filed: 05/02/2012
• Published: 05/09/2013
• Est. Priority Date: 05/31/2007
• Status: Abandoned Application

• Current Assignee: Regents of the University of California (University of California)
• Original Assignee: Regents of the University of California (University of California)
• Inventors: Wei, Fang, Wong, David T. W., Zimmerman, Bernhard G.
• Application Number:
  US13/462,709
• Publication Number:
  US 20130115594A1
• Time in Patent Office: Days
• US Class Current: 435/6.11
• CPC Class Codes: C12Q 1/682 Signal amplification
• CPC Class Codes: C12Q 1/6825 Nucleic acid detection involving sensors
• CPC Class Codes: C12Q 1/6876 Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
• CPC Class Codes: C12Q 2525/301 Hairpin oligonucleotides
• CPC Class Codes: C12Q 2563/131 the label being a member of a cognate binding pair, i.e. extends to antibodies, haptens, avidin
• CPC Class Codes: C12Q 2565/1025 labels being on the same oligonucleotide
• CPC Class Codes: C12Q 2565/107 Alteration in the property of hybridised versus free label oligonucleotides
• CPC Class Codes: C12Q 2565/501 being an array of oligonucleotides

Abstract

The present invention relates to a molecular probe capable of high sensitivity and high specificity detection of a target nucleic acid in a sample. Also disclosed is a detection method using this probe.

Claims

1. (canceled)

2. (canceled)

3. (canceled)

4. (canceled)

5. (canceled)

6. (canceled)

7. (canceled)

8. (canceled)

9. (canceled)

10. (canceled)

11. (canceled)

12. (canceled)

13. A method of assaying a target nucleic acid molecule in a sample, the method comprising:

contacting a probe comprising a ligand and a polynucleotide sequence, wherein the polynucleotide sequence is capable of forming a hairpin and the polynucleotide sequence comprises a 5′

domain and a 3′

domain, wherein the 5′

domain comprises the first six to 10 nucleotides of the 5′

end of the polynucleotide sequence and the 5′

domain is not complementary to the target nucleic acid molecule and wherein the 3′

domain is from 27 to 41 nucleotides in length and can specifically hybridize to a sequence of the target nucleic acid molecule, and is capable of hybridizing with the 5′

domain, wherein hybridization of the 5′ and

3′

domains would produce a loop of at least 21 nucleotides and wherein the polynucleotide sequence is no longer than 51 nucleotides, the probe having a first three-dimensional structure in the absence of the target nucleic acid molecule being bound thereto and a second three-dimensional structure in the presence of the target nucleic acid being bound thereto, wherein the first three-dimensional structure inhibits or prevents the ligand from binding a receptor and the second three-dimensional structure allows the ligand to bind to the receptor., thereby forming a ligand receptor complex wherein the ligand receptor complex results in a detectable signal wherein the detectable signal increases as the number of nucleotides in the 5′

domain increases from six to 10.

14. The method of claim 13, wherein the receptor comprises a detectable label.

15. The method of claim 14, and further comprising amplifying the detection signal from the detectable label.

16. The method of claim 13, wherein the first three-dimensional structure sterically hinders the receptor from binding the ligand.

17. The method of claim 13, wherein the probe is immobilized on a substrate.

18. The method of claim 17, wherein the first-three dimensional structure places the ligand at a position near the substrate such that the receptor is inhibited or prevented from binding the ligand.

19. The method of claim 13, wherein the receptor is an antibody that specifically binds the ligand.

20. The method of claim 13, wherein the detectable label is fluorescein, streptavidin or biotin.

21. The method of claim 15, wherein the detection signal from the detectable label is amplified by peroxidase, laccase, glucose oxidase, alkaline phosphatease, or urease.

23. The method of claim 13, further comprising removing any receptor unbound to the ligand prior to detecting the complex.

24. The method of claim 13, wherein the target nucleic acid molecule is an IL-8 nucleic acid.

25. The method of claim 13, wherein the polynucleotide sequence is selected from SEQ ID NO:

2, 3, and 4.

22. (canceled)